James Sostak, MD
Sports Medicine · Geneva, ILNPI 1235200833
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,867 of the $2,598 with a category attached, or 71.8%. 17 manufacturers reported payments, led by Arthrex at 30.6% of the total. Reporting peaked in 2020 at $1,391 and has fallen 84.1% since, to $221 in 2025.
Across 67 payments — averaging $38.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$795
- Amgen$386
- Medwest Associates$326
- Catalyst Orthoscience$254
- Zimmer Biomet$180
- Johnson & Johnson$137
- plus $520 from 11 others
What the payments were for
- Travel & lodging$73228%
- Food & beverage$1,86772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 4 | $795 |
| Amgen(2 entities) | 21 | $386 |
| Medwest Associates | 1 | $326 |
| Catalyst Orthoscience | 8 | $254 |
| Zimmer Biomet | 9 | $180 |
| Johnson & Johnson(2 entities) | 3 | $137 |
| Highridge Medical LLC | 4 | $91 |
| Stryker | 2 | $81 |
| Smith+Nephew | 2 | $76 |
| Fidia Pharma USA Inc. | 3 | $59 |
| Dynasplint Systems Inc. | 1 | $50 |
| Terumo BCT, Inc. | 3 | $43 |
| Globus Medical | 1 | $41 |
| EBI, LLC | 2 | $27 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Radius Health, Inc. | 1 | $15 |
| Pacira Therapeutics, Inc. | 1 | $12 |
How this compares
$2,598 in reported general payments places this provider in the 60th percentile of 233 sports medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 83 | $230 |
| Methylprednisolone | 39 | $194 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $186 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Geneva
- Vishal MehtaGeneva$59K
- Benjamin DombDes Plaines$16.3M
- Gregory NicholsonChicago$6.7M
- Grant GarriguesChicago$2.5M
- Brian ColeChicago$2.1M
- Brian ForsytheChicago$1.9M
- Nikhil VermaChicago$647K
- Shane NhoChicago$521K
- Jourdan CancienneJoliet$224K
- Vehniah TjongChicago$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.